Clinical trials for Anaplastic astrocytoma
30 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- ACTIVE NOT RECRUITINGNCT07448480Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant GliomasBlokhin's Russian Cancer Research Center · PI: David Naskhletashvili, MD, PhD
- RECRUITINGEarly Phase 1NCT06333899Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK FusionNationwide Children's Hospital · PI: Hamza Gorsi, MD
- RECRUITINGPHASE1, PHASE2NCT05956821Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of AgeUniversity of Miami · PI: Heather McCrea, MD
- ACTIVE NOT RECRUITINGPhase 1NCT06614855A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant GliomaJames Markert, MD
- RECRUITINGPhase 2NCT06161974Study of Olutasidenib and Temozolomide in HGGRigel Pharmaceuticals · PI: Santosh Valvi, FRACP, MSc
- RECRUITINGPhase 2NCT05843253Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutantNationwide Children's Hospital · PI: Margot Lazow, MD
- RECRUITINGNCT05839379Targeted Pediatric High-Grade Glioma TherapyNationwide Children's Hospital · PI: Maryam Fouladi, MD
- RECRUITINGPhase 2NCT06264388DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic AstrocytomaAshish Shah · PI: Ashish Shah, MD
- RECRUITINGPhase 1NCT05698524A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent GliomaUniversity of Nebraska · PI: Nicole A Shonka, MD
- ACTIVE NOT RECRUITINGPhase 1NCT04978727A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine GliomaChildren's Oncology Group · PI: Clare Twist, MD
- RECRUITINGPHASE1, PHASE2NCT05084430Study of Pembrolizumab and M032 (NSC 733972)University of Alabama at Birmingham · PI: James Markert, MD
- RECRUITINGEarly Phase 1NCT04135807Implantable Microdevice In Primary Brain TumorsOliver Jonas · PI: Pier Paolo Peruzzi, MD, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT03919071Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade GliomaNational Cancer Institute (NCI) · PI: Rishi R Lulla
- RECRUITINGPhase 2NCT04623931Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) GlioblastomasM.D. Anderson Cancer Center · PI: Debra N Yeboa
- ACTIVE NOT RECRUITINGPhase 1NCT04197934WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System MetastasesMayo Clinic · PI: Sani H. Kizilbash, M.D., M.P.H.
- ACTIVE NOT RECRUITINGPhase 1NCT03657576Trial of C134 in Patients With Recurrent GBMUniversity of Alabama at Birmingham · PI: James Markert, MD
- RECRUITINGPhase 1NCT03911388HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsM.D. Anderson Cancer Center · PI: Gregory Friedman, MD
- ACTIVE NOT RECRUITINGEarly Phase 1NCT03893487Fimepinostat in Treating Brain Tumors in Children and Young AdultsSabine Mueller, MD, PhD · PI: Sabine Mueller, MD, PhD
- ACTIVE NOT RECRUITINGPhase 1NCT03528642Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic AstrocytomaNational Cancer Institute (NCI) · PI: Sani H Kizilbash
- RECRUITINGPhase 1NCT03896568MSC-DNX-2401 in Treating Patients With Recurrent High-Grade GliomaM.D. Anderson Cancer Center · PI: Frederick F Lang
- ACTIVE NOT RECRUITINGPhase 2NCT03581292Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 MutationsNational Cancer Institute (NCI) · PI: Matthias A Karajannis
- RECRUITINGPHASE1, PHASE2NCT03603405HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBMThe Methodist Hospital Research Institute · PI: David S. Baskin, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03180502Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III GliomaNRG Oncology · PI: David R Grosshans
- RECRUITINGNCT04780009Loupe-Based Intraoperative Fluorescence ImagingGuoqiang Yu · PI: Guoqiang Yu, PhD
- ACTIVE NOT RECRUITINGPhase 1NCT03152318A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2Dana-Farber Cancer Institute · PI: E. Antonio Chiocca, MD, PhD
- RECRUITINGPhase 2NCT02800486Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOANorthwell Health · PI: John Boockvar, MD
- ACTIVE NOT RECRUITINGPhase 1NCT02192359Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade GliomasCity of Hope Medical Center · PI: Jana L Portnow
- ACTIVE NOT RECRUITINGPhase 1NCT02062827Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant GliomaUniversity of Alabama at Birmingham · PI: James M. Markert, MD
- RECRUITINGPHASE1, PHASE2NCT01269853Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AANorthwell Health · PI: John Boockvar, MD
- ACTIVE NOT RECRUITINGPhase 1NCT00268385Vorinostat and Temozolomide in Treating Patients With Malignant GliomasNational Cancer Institute (NCI) · PI: Patrick Y Wen